PTEN and systemic sclerosis: Aside from pioneer studies showing that the phosphoinositide phosphatase PTEN displays reduced expression in SSc dermal fibroblasts (DF)4, 10, only the oxidative inhibition of the tyrosine-specific phosphatase PTP1B has been shown to be involved in promoting platelet-derived growth factor signaling in SSc fibroblasts11.